Macquarie Group LTD Galapagos Nv Transaction History

Macquarie Group LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$76.15 - $111.94 $81,937 - $120,447	-1,076 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$96.85 - $148.25 $408,416 - $625,170	-4,217 Reduced 79.67%	1,076 $107,000
Q3 2020 Nov 13, 2020	SELL	$122.47 - $213.56 $20,697 - $36,091	-169 Reduced 3.09%	5,293 $751,000
Q2 2020 Aug 11, 2020	SELL	$185.52 - $231.25 $98,140 - $122,331	-529 Reduced 8.83%	5,462 $1.08 Million
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $287,859 - $551,622	-2,013 Reduced 25.15%	5,991 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $132,969 - $196,396	910 Added 12.83%	8,004 $1.66 Million
Q3 2019 Nov 14, 2019	SELL	$130.44 - $187.64 $34,957 - $50,287	-268 Reduced 3.64%	7,094 $1.08 Million
Q2 2019 Aug 14, 2019	SELL	$111.45 - $128.93 $56,616 - $65,496	-508 Reduced 6.45%	7,362 $949,000
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $9,140 - $12,013	102 Added 1.31%	7,870 $927,000
Q4 2018 Feb 15, 2019	BUY	$87.81 - $110.65 $17,737 - $22,351	202 Added 2.67%	7,768 $713,000
Q3 2018 Nov 15, 2018	SELL	$90.63 - $120.22 $208,358 - $276,385	-2,299 Reduced 23.3%	7,566 $851,000
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $103,428 - $123,247	1,170 Added 13.46%	9,865 $909,000
Q1 2018 May 11, 2018	SELL	$94.51 - $120.23 $85,531 - $108,808	-905 Reduced 9.43%	8,695 $867,000
Q4 2017 Feb 15, 2018	BUY	$84.48 - $104.02 $81,354 - $100,171	963 Added 11.15%	9,600 $900,000
Q3 2017 Nov 08, 2017	BUY	$73.17 - $103.47 $631,969 - $893,670	8,637	8,637 $879,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.